Vivos Therapeutics (VVOS) Other Accumulated Expenses (2022 - 2026)
Vivos Therapeutics (VVOS) reported Other Accumulated Expenses of $1.2 million for Q1 2026, up 83.63% year-over-year from $672000.0 in Q1 2025, and up 45.18% on a QoQ basis from $850000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 5 years of Other Accumulated Expenses data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Other Accumulated Expenses rose 83.63% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 83.63% YoY) and the FY2025 annual result came in at $850000.0, up 211.36% from the prior year.
- Other Accumulated Expenses grew to $1.2 million in Q1 2026 per VVOS's latest filing, from $850000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.2 million in Q1 2026 and bottomed at $127000.0 in Q1 2023.
- The 5-year median for Other Accumulated Expenses is $278500.0 (2023), against an average of $448375.0.
- The widest annual swing landed in 2023, when Other Accumulated Expenses slumped 55.68%; it then soared 572.19% in 2025.
- Tracing VVOS's Other Accumulated Expenses over 5 years: stood at $145000.0 in 2022, then soared by 36.55% to $198000.0 in 2023, then jumped by 37.88% to $273000.0 in 2024, then soared by 211.36% to $850000.0 in 2025, then surged by 45.18% to $1.2 million in 2026.
- Per Business Quant, the three latest VVOS Other Accumulated Expenses figures stand at $1.2 million (Q1 2026), $850000.0 (Q4 2025), and $987000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 850,000.00 |
| Sep 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 672,000.00 |
| Dec 31, 2024 | 273,000.00 |
| Sep 30, 2024 | 199,000.00 |
| Jun 30, 2024 | 151,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 284,000.00 |
| Jun 30, 2023 | 160,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Sep 30, 2022 | 294,000.00 |
| Jun 30, 2022 | 361,000.00 |